Multidrug-resistant tuberculosis prevalence is 5.2% among patients with bacteriologically confirmed cases in Cameroon
Identifying key risks for drug resistant tuberculosis infections in Cameroon
This meta-analysis of 28 studies involving 9,931 patients identifies a 5.2% pooled prevalence of multidrug-resistant tuberculosis (MDR-TB) i…
New data shows that past infections and lifestyle factors like alcohol use can increase the risk of developing hard-to-treat tuberculosis.
Pooled Salmonella prevalence in Ethiopia is 6.7% with significant regional and source variations
Tracking Salmonella Bacteria and Drug Resistance Across Different Areas of Ethiopia
This meta-analysis of 43 datasets from 39 articles identifies a pooled Salmonella prevalence of 6.7% (95% CI: 5.3-8.1%) across human, animal…
New data shows how common Salmonella is in people, animals, and the environment while tracking how well it resists common medicines.
Narrative review suggests phytochemicals and phages may augment conventional antibiotics for brucellosis
New plant-based and phage options might help treat stubborn brucellosis infections in people and animals
This narrative review discusses novel strategies for treating brucellosis in humans and animals. The authors note that conventional antibiot…
Standard antibiotics sometimes fail to cure brucellosis, and bacteria are becoming resistant. New methods using plant chemicals and viruses …
In vitro amikacin resistance linked to kanamycin cross-resistance but not streptomycin in M. avium-intracellulare complex
Lost to Amikacin? Streptomycin Might Still Work
This single-center retrospective study evaluated cross-resistance among aminoglycosides in 20 patients with amikacin-resistant M.
When amikacin fails to treat stubborn lung infections, streptomycin often remains effective, offering hope for patients facing drug-resistan…
Guidelines outline antimicrobial treatment and prophylaxis recommendations for human plague
Health experts issue updated treatment guidelines for plague infections
A guideline document provides recommended best practices for antimicrobial treatment and prophylaxis of human plague in naturally acquired i…
Updated guidelines now tell doctors how to treat and prevent plague infections from natural outbreaks or bioterrorism attacks.